Apollo Hospitals' Lower Margins Explained: Diversified Business Model Impact on Profitability
Published on: Jan. 10, 2026, 9:13 p.m. | Source: scanx.trade
Apollo Hospitals reports lower consolidated margins (15% EBITDA, 7.8% net) compared to peers due to diversified business model including low-margin pharmacy distribution (₹2,660 cr revenue, ₹73 cr profit) and loss-making diagnostics (₹474 cr revenue, ₹6 cr loss). Standalone hospital operations achieve competitive 25% EBITDA margin, indicating core business strength. Company is demerging pharmacy and digital health businesses to unlock value and improve margin clarity.
